Related Research Articles
Baldomero Olivera is a Filipino chemist known for discovery of many cone snail toxins important for neuroscience. These molecules, called conotoxins, led to a breakthrough in the study of ion channels and neuromuscular synapses. He discovered and first characterized E. coli DNA ligase, a key enzyme of genetic engineering and recombinant DNA technology.
William Ogden "Doc" Farber was an American political scientist, professor emeritus at the University of South Dakota, and founder of the South Dakota Legislative Research Council. Notable protégés that credit his teachings as influences include Tom Brokaw, Al Neuharth, Dennis Daugaard, Dusty Johnson, and Pat O'Brien.
William S. Dalton is an American physician and oncologist, who is board certified in internal medicine and oncology. Since 2002 he has been the President, CEO, and Center Director of the H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida (USF). He served as dean of the University of Arizona College of Medicine, 2001-2002.
The College of Natural Science (NatSci) at Michigan State University is home to 27 departments and programs in the biological, physical and mathematical sciences.
Jonathan W. Simons is an American physician-scientist, medical oncologist, and leader in prostate cancer research. In August 2021, Simons was appointed the medical director and Chief Science Officer of the Marcus Foundation. Prior to joining the Marcus Foundation, he served a 14-year tenure as the President and chief executive officer of the Prostate Cancer Foundation. Simons’ laboratories, partly funded by the Prostate Cancer Foundation, at Johns Hopkins University and Emory University made original contributions to understanding the molecular biology of prostate cancer metastasis and principles of “broken immune tolerance” via T cell based immunotherapy for prostate cancer. The Simons lab invented GM-CSF genetically engineered vaccines for prostate cancer in rodents and humans for these studies, and subsequently Simons’ clinical team took the biotechnology into the world’s first human gene therapy clinical trials for advanced prostate cancer at Johns Hopkins.
Arvind Varma was the R. Games Slayter Distinguished Professor, School of Chemical Engineering at Purdue University. His research interests are in chemical and catalytic reaction engineering, and new energy sources.
Raymond L. Woosley, M.D., Ph.D. is the founding president and chairman of the board for AZCERT, a not-for-profit organization dedicated to improved outcomes from the use of medications. Prior to leading AZCERT, he was founder and President of Critical Path Institute. C-Path is an independent, non-profit organization created by the U.S. Food and Drug Administration (FDA) and the University of Arizona to help launch the critical path initiative. Previously, he has served as Vice-President for Health Sciences and Dean of the College of Medicine at the University of Arizona. He is currently Professor of Medicine and Biomedical Informatics in the University of Arizona College of Medicine - Phoenix, Arizona.
Jeffrey A. Brent is a medical toxicologist who is a distinguished clinical professor of medicine and emergency medicine at the University of Colorado, School of Medicine. In addition, he is a professor at the Department of Environmental and Occupational Health at the Colorado School of Public Health. He is also the past president of the American Academy of Clinical Toxicology, was editor in chief of the journal Toxicological Reviews, and was a member of the board of directors of the American College of Medical Toxicology. Previously, most of Brent's research focused on the use of fomepizole as a treatment for both methanol and ethylene glycol poisoning, and he led a trial of this drug which resulted in the FDA approving it in December 1997. Currently, Brent serves as Director of the Toxicology Investigators Consortium, an NIH and FDA supported multi center research and surveillance group. Brent is also a senior editor of "Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient," originally published in 2005, and now in its second edition, which was published in 2017.
Toshio Narahashi was an internationally known pharmacologist. He was the John Evans Professor of Pharmacology and former chair of the Department of Pharmacology at Northwestern University Feinberg School of Medicine, where he served on the faculty from 1977 to 2013. Prior, he was vice chairman of the Department of Physiology and Pharmacology at Duke University, where he served on the faculty from 1962 to 1977. He is considered by many to be the "founding father of neurotoxicology" and is credited with discovering how tetrodotoxin, the poison in puffer fish, immobilizes parts of the nervous system.
Purnendu K. Dasgupta is a professor of chemistry and biochemistry at the University of Texas at Arlington.
Seymour I. Schwartz, was the Distinguished Alumni Professor for the Department of Surgery at the University of Rochester in Rochester, New York. He was one of the most prolific and honored surgeons in American history with further successes outside of the field of medicine as a renowned author and cartographic historian. His most notable accomplishments in surgery include being the founding editor-in-chief of Schwartz's Principles of Surgery, Chairman of the Department of Surgery at the University of Rochester (1987-1998), Editor-in-Chief of the Journal of the American College of Surgeons (1996-2004) and President of the American College of Surgeons (1997-1998). After spending nearly 65 years in the field of surgery, he has published hundreds of research articles, textbook chapters, and received numerous honors in the United States and abroad. Schwartz has lectured throughout the world as a visiting professor and donated to many philanthropic endeavors. His influence on surgical education and leadership has impacted nearly every practicing surgeon in the world. Throughout his career, Schwartz has treated and changed the lives of tens of thousands of patients and trained generations of residents and fellows to share in his legacy and do the same.
John Doull was Professor of Pharmacology and Toxicology at the University of Kansas.
Daniel M. Albert is an American ophthalmologist, ocular cancer researcher, medical historian, and collector of rare books and ocular equipment. As of 2018, he is Professor of Ophthalmology at the Casey Eye Institute, Oregon Health & Science University.
Holly Brown-Borg is an American biologist and biogerontologist best known for her research on the regulation of lifespan by growth hormone. She is the Chester Fritz Distinguished Professor of Pharmacology, Physiology & Therapeutics at the University of North Dakota School of Medicine and Health Sciences.
James L. Skinner is an American theoretical chemist. He is the Joseph O. and Elizabeth S. Hirschfelder Professor Emeritus at the University Wisconsin-Madison. He is also a member of the Scientific Advisory Board of the Welch Foundation. Most recently, Skinner was the Crown Family Professor of Molecular Engineering, Professor of Chemistry, Director of the Water Research Initiative and Deputy Dean for Faculty Affairs of the Pritzker School of Molecular Engineering at the University of Chicago. Skinner is recognized for his contributions to the fields of theoretical chemistry, nonequilibrium statistical mechanics, linear and nonlinear spectroscopy of liquids, amorphous and crystalline solids, surfaces, proteins, and supercritical fluids. Skinner is the co-author of over 230 peer-reviewed research articles.
Dr. Dolores C. Shockley was the first black woman to receive a PhD in pharmacology in the United States and one of the first African American students to receive a PhD from Purdue University. After obtaining her PhD she became faculty at the historically black school Meharry Medical College where she subsequently became the first black woman to chair a Pharmacology department in the United States in 1988. Her research contributions included studying the effects of chemical pollutants on the brain and identifying pharmacological agents that interact with drugs of abuse such as cocaine. She was a distinguished scholar and emeritus professor at Meharry Medical College.
Julie Ann Johnson is an American clinical pharmacist and translational scientist. She is the past dean (2013-2022) and a distinguished professor in the University of Florida College of Pharmacy and a Member of the National Academy of Medicine. For four consecutive years, she was a Clarivate Analytics Highly Cited Researcher in Pharmacology and Toxicology, indicating she was one of the "world's leading scholars in the sciences and social sciences in the preceding decade."
Paul Anthony Insel is an American physician and pharmacologist. He has been the chief editor of four academic journals and is an elected fellow of the American Association for the Advancement of Science, American Society for Pharmacology and Experimental Therapeutics, and American Physiological Society. His research is primarily focused on G proteins.
Matthias Schwab is a German doctor and university lecturer. He is director of the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology located on the campus of the Robert-Bosch-Hospital in Stuttgart, an institution of the Robert Bosch Stiftung, and holder of the Chair of Clinical Pharmacology at the University of Tübingen as well as Medical Director of the Department of Clinical Pharmacology at the University Hospital Tübingen.
Talmage D. Egan is an anesthesiologist, academic, entrepreneur, and author. He is a professor and chair in the department of Anesthesiology, and an adjunct professor in the departments of Pharmaceutics, Bioengineering, and Neurosurgery at the University of Utah School of Medicine.
References
- 1 2 "David W. Hein". louisville.edu.
| Authority control: Academics |
|---|
